momelotinib

Showing 2 posts of 2 posts found.

testalize-me-0je8ynv4mis-unsplash

GSK gains positive CHMP opinion for momelotinib for myelofibrosis treatment

November 13, 2023
Medical Communications CHMP, GSK, Haematology, anaemia, momelotinib, myelofibrosis

GSK has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has …

GSK announces extension of FDA’s review for momelotinib

June 20, 2023
Medical Communications FDA, GSK, Oncology, momelotinib, new drug application

GSK has announced that the US Food and Drug Administration (FDA) has extended its review period for the new drug …

Latest content